292 related articles for article (PubMed ID: 24749785)
21. Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models.
Torben W; Ahmad G; Zhang W; Siddiqui AA
Vaccine; 2011 Mar; 29(12):2262-71. PubMed ID: 21277404
[TBL] [Abstract][Full Text] [Related]
22. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
Tallima H; Tadros MM; El Ridi R
Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620
[TBL] [Abstract][Full Text] [Related]
23. The 14-3-3 protein as a vaccine candidate against schistosomiasis.
Schechtman D; Tarrab-Hazdai R; Arnon R
Parasite Immunol; 2001 Apr; 23(4):213-7. PubMed ID: 11298298
[TBL] [Abstract][Full Text] [Related]
24. Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine.
Ahmad G; Zhang W; Torben W; Haskins C; Diggs S; Noor Z; Le L; Siddiqui AA
Parasitol Res; 2009 Nov; 105(6):1767-77. PubMed ID: 19809833
[TBL] [Abstract][Full Text] [Related]
25. Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine.
Pacífico LG; Fonseca CT; Chiari L; Oliveira SC
Immunobiology; 2006; 211(1-2):97-104. PubMed ID: 16446174
[TBL] [Abstract][Full Text] [Related]
26. The Schistosoma bovis Sb14-3-3zeta recombinant protein cross-protects against Schistosoma mansoni in BALB/c mice.
Siles-Lucas M; Uribe N; López-Abán J; Vicente B; Orfao A; Nogal-Ruiz JJ; Feliciano AS; Muro A
Vaccine; 2007 Oct; 25(41):7217-23. PubMed ID: 17707955
[TBL] [Abstract][Full Text] [Related]
27. Solution structure, membrane interactions, and protein binding partners of the tetraspanin Sm-TSP-2, a vaccine antigen from the human blood fluke Schistosoma mansoni.
Jia X; Schulte L; Loukas A; Pickering D; Pearson M; Mobli M; Jones A; Rosengren KJ; Daly NL; Gobert GN; Jones MK; Craik DJ; Mulvenna J
J Biol Chem; 2014 Mar; 289(10):7151-7163. PubMed ID: 24429291
[TBL] [Abstract][Full Text] [Related]
28. Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice.
Yang W; Jackson DC; Zeng Q; McManus DP
Vaccine; 2000 Aug; 19(1):103-13. PubMed ID: 10924792
[TBL] [Abstract][Full Text] [Related]
29. Proteosome delivery of a protective 9B-antigen against Schistosoma mansoni.
Tarrab-Hazdai R; Schechtman D; Lowell G; Pirak E; Arnon R
Int J Immunopharmacol; 1999 Mar; 21(3):205-18. PubMed ID: 10348370
[TBL] [Abstract][Full Text] [Related]
30. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni.
Allam G
Immunobiology; 2009; 214(8):712-27. PubMed ID: 19249123
[TBL] [Abstract][Full Text] [Related]
31. Aluminum hydroxide associated to Schistosoma mansoni 22.6 kDa protein abrogates partial protection against experimental infection but not alter interleukin-10 production.
Pacífico LG; Fonseca CT; Barsante MM; Cardoso LS; Araújo MI; Oliveira SC
Mem Inst Oswaldo Cruz; 2006 Sep; 101 Suppl 1():365-8. PubMed ID: 17308799
[TBL] [Abstract][Full Text] [Related]
32. Vaccination of mice with a 30 kDa Schistosoma antigen with and without human adjuvant induces high protection against S. mansoni infection.
Attallah AM; Abdel Aziz MM; Abbas AT; Elbakry KA; El-Sharabasy MM
J Helminthol; 2004 Sep; 78(3):189-94. PubMed ID: 15469619
[TBL] [Abstract][Full Text] [Related]
33. Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.
Zhang W; Ahmad G; Torben W; Noor Z; Le L; Damian RT; Wolf RF; White GL; Chavez-Suarez M; Podesta RB; Kennedy RC; Siddiqui AA
J Infect Dis; 2010 Apr; 201(7):1105-12. PubMed ID: 20187746
[TBL] [Abstract][Full Text] [Related]
34. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
[TBL] [Abstract][Full Text] [Related]
35. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection.
Da'Dara AA; Skelly PJ; Walker CM; Harn DA
Parasite Immunol; 2003; 25(8-9):429-37. PubMed ID: 14651590
[TBL] [Abstract][Full Text] [Related]
36. Papain-Based Vaccination Modulates Schistosoma mansoni Infection-Induced Cytokine Signals.
Abdel Aziz N; Tallima H; Hafez EA; El Ridi R
Scand J Immunol; 2016 Feb; 83(2):128-38. PubMed ID: 26603950
[TBL] [Abstract][Full Text] [Related]
37. [Enhancement of the protective effect of SjC23 DNA vaccine against Schistosoma japonicum infection by immunostimulatory sequence].
Zhao S; Zhu YC; Harn DA; Si J; Ren JG; Yin XR; He W; Liang YS; Xu M; Xu YL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 16042196
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-12 as an adjuvant for an antischistosome vaccine consisting of adult worm antigens: protection of rats from cercarial challenge.
Bungiro RD; Goldberg M; Suri PK; Knopf PM
Infect Immun; 1999 May; 67(5):2340-8. PubMed ID: 10225893
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of Schistosoma mansoni tegument annexins and comparative analysis of antibody responses following parasite infection.
Leow CY; Willis C; Leow CH; Hofmann A; Jones M
Mol Biochem Parasitol; 2019 Dec; 234():111231. PubMed ID: 31628972
[TBL] [Abstract][Full Text] [Related]
40. Investigating Immunization With Nucleotide Enzymes of
Cagnazzo TDO; Nogueira CT; de Castro CA; Neris DM; Fattori ACM; Correia RO; Albuquerque YR; Fragelli BDL; Mendes TMF; Allegretti SM; Soares EG; Romanello L; Torini JR; Pereira HD; Anibal FF
Front Immunol; 2020; 11():569988. PubMed ID: 33072110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
